Placental treatment with insulin-like growth factor 1 via nanoparticle differentially impacts vascular remodeling factors in guinea pig sub-placenta/decidua
Clinically, fetal growth restriction (FGR) is only detectable in later gestation, despite pathophysiological establishment likely earlier in pregnancy. Additionally, there are no effective in utero treatment options for FGR. We have developed a nanoparticle to deliver human insulin-like 1 growth fac...
Main Authors: | Baylea N. Davenport, Helen N. Jones, Rebecca L. Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2022.1055234/full |
Similar Items
-
Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction
by: Lewis J. Renshall, et al.
Published: (2021-10-01) -
The role of placental tryptophan catabolism
by: Peter eSedlmayr, et al.
Published: (2014-05-01) -
Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction
by: Kyoka Tsuchiya, et al.
Published: (2020-12-01) -
Hydroxychloroquine in obstetrics: potential implications of the prophylactic use of hydroxychloroquine for placental insufficiency during pregnancy
by: Yoo-Min Kim, et al.
Published: (2024-03-01) -
Environmental cadmium exposure induces fetal growth restriction via triggering PERK-regulated mitophagy in placental trophoblasts
by: Hua-Long Zhu, et al.
Published: (2021-02-01)